Literature DB >> 16824847

The effect of patient sex on recurrence of atrial fibrillation following successful direct current cardioversion.

Osnat T Gurevitz1, Chitra J Varadachari, Naser M Ammash, Joseph F Malouf, A Gabriela Rosales, Regina M Herges, Charles J Bruce, Virend K Somers, Stephen C Hammill, Bernard J Gersh, Paul A Friedman.   

Abstract

BACKGROUND: The effect of patient sex on recurrence of atrial fibrillation after a successful direct current cardioversion is unknown.
METHODS: This prospective study included 773 patients (486 [63%] men and 287 [37%] women) undergoing successful direct current cardioversion of atrial fibrillation between May 2000 and July 2003. Patient characteristics at presentation were recorded. The primary end point was the time between cardioversion and the first documented recurrence of arrhythmia.
RESULTS: At presentation, women were older and had a higher prevalence of hypertension and valvular disease compared with men. In addition, women had worse mechanical left atrial appendage function. Arrhythmia recurrence was more prevalent in women (50.0% at 1 year compared with 43.4% in men, and 75.8% at 2 years compared with 67.0% in men; P = .03). On the basis of multivariate analysis, patient sex was a significant predictor of arrhythmia recurrence. There was no significant difference in overall mortality between men and women.
CONCLUSIONS: Women were more likely than men to have recurrence of atrial fibrillation after successful direct current cardioversion. Patient sex should be taken into account with other clinical factors when making the decision about cardioversion for atrial fibrillation.

Entities:  

Mesh:

Year:  2006        PMID: 16824847     DOI: 10.1016/j.ahj.2006.04.030

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  11 in total

Review 1.  A review of factors associated with maintenance of sinus rhythm after elective electrical cardioversion for atrial fibrillation.

Authors:  Veronika Ecker; Charles Knoery; Gordon Rushworth; Ian Rudd; Astrid Ortner; David Begley; Stephen J Leslie
Journal:  Clin Cardiol       Date:  2018-06-07       Impact factor: 2.882

2.  Risk factors for recurrence of atrial fibrillation.

Authors:  Antoniya Kisheva; Yoto Yotov
Journal:  Anatol J Cardiol       Date:  2021-05       Impact factor: 1.596

Review 3.  Atrial fibrillation in women: treatment.

Authors:  Darae Ko; Faisal Rahman; Maria A P Martins; Elaine M Hylek; Patrick T Ellinor; Renate B Schnabel; Emelia J Benjamin; Ingrid E Christophersen
Journal:  Nat Rev Cardiol       Date:  2016-10-27       Impact factor: 32.419

4.  Bipolar Disorder and Schizophrenia Present Different Risks of Atrial fibrillation: A Nationwide Population-Based Analysis.

Authors:  Hung-Yu Yang; Jen-Hung Huang; Yung-Kuo Lin; Chien-Yeh Hsu; Shih-Ann Chen; Yi-Jen Chen
Journal:  Acta Cardiol Sin       Date:  2014-01       Impact factor: 2.672

5.  Baseline NT-Pro-BNP levels and arrhythmia recurrence in outpatients undergoing elective cardioversion of persistent atrial fibrillation: a survival analysis.

Authors:  Tommaso Sanna; Andrea Sonaglioni; Maurizio Pieroni; Antonio Dello Russo; Gemma Pelargonio; Michela Casella; Evelina Zichichi; Giuseppe La Torre; Maria Lucia Narducci; Fulvio Bellocci
Journal:  Indian Pacing Electrophysiol J       Date:  2009-01-07

Review 6.  Women and atrial fibrillation.

Authors:  Annabelle Santos Volgman; Emelia J Benjamin; Anne B Curtis; Margaret C Fang; Kathryn J Lindley; Gerald V Naccarelli; Carl J Pepine; Odayme Quesada; Marmar Vaseghi; Albert L Waldo; Nanette K Wenger; Andrea M Russo
Journal:  J Cardiovasc Electrophysiol       Date:  2020-12-29       Impact factor: 2.942

7.  Role for machine learning in sex-specific prediction of successful electrical cardioversion in atrial fibrillation?

Authors:  Nicklas Vinter; Anne Sofie Frederiksen; Andi Eie Albertsen; Gregory Y H Lip; Morten Fenger-Grøn; Ludovic Trinquart; Lars Frost; Dorthe Svenstrup Møller
Journal:  Open Heart       Date:  2020-06

8.  Clinical factors related to successful or unsuccessful cardioversion in the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) randomized trial.

Authors:  Gregory Y H Lip; Jose L Merino; Maciej Banach; Naab Al-Saady; James Jin; Michael Melino; Shannon M Winters; Monika Kozieł; Andreas Goette
Journal:  J Arrhythm       Date:  2020-04-15

9.  Transvenous electrical cardioversion of atrial fibrillation in horses: Horse and procedural factors correlated with success and recurrence.

Authors:  Ingrid Vernemmen; Glenn Van Steenkiste; Alexander Dufourni; Annelies Decloedt; Gunther van Loon
Journal:  J Vet Intern Med       Date:  2022-03-05       Impact factor: 3.333

10.  Family history as a risk factor for recurrent hospitalization for lone atrial fibrillation: a nationwide family study in Sweden.

Authors:  Bengt Zöller; Henrik Ohlsson; Jan Sundquist; Kristina Sundquist
Journal:  BMC Cardiovasc Disord       Date:  2012-12-10       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.